Medtronic (NYSE: MDT) — Company Overview, News & Financial Data
Medtronic develops innovative medical technologies to improve health outcomes across diverse conditions.
Medtronic
Medtronic is a global healthcare technology company that designs, manufactures, and distributes medical devices and therapies to hospitals, physicians, and patients across more than 150 countries. The company operates through four primary segments: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. Its product lines encompass cardiac rhythm management systems, structural heart devices, surgical robotics, spinal implants, deep brain stimulation devices, patient monitoring solutions, and continuous glucose monitoring technologies. Headquartered in Dublin, Ireland, with operational headquarters in Minneapolis, Minnesota, the business conducts extensive research and development to advance minimally invasive procedures, digital health ecosystems, and chronic disease management therapies.
Snapshot
Operations
Products and/or services of Medtronic
- Cardiovascular Portfolio: Development and manufacturing of cardiac rhythm management systems, transcatheter aortic valves, pacemakers, implantable cardioverter defibrillators, coronary stents, and ablation systems designed for treating vascular diseases and structural heart conditions worldwide.
- Medical Surgical Portfolio: Advanced surgical instruments, electrosurgical hardware, surgical stapling products, wound closure tools, and patient monitoring technologies supplied to hospitals and ambulatory surgery centers globally for minimally invasive and open operative procedures.
- Neuroscience Portfolio: Products and therapies for spinal, cranial, and neurological disorders, including spinal implants, deep brain stimulation systems, surgical navigation systems, and targeted drug infusion pumps used across international healthcare facilities.
- Diabetes Operating Unit: Integrated diabetes management solutions comprising automated insulin delivery systems, continuous glucose monitors, smart insulin pens, and digital software applications serving adult and pediatric patients with type 1 and type 2 diabetes.
- Robotic-Assisted Surgery: Mobile robotic-assisted surgery systems, digital ordering and procedural software, and integrated surgical ecosystem platforms designed to assist clinical teams in planning, executing, and refining complex laparoscopic and soft-tissue procedures.
- Neuromodulation and Pelvic Health: Implantable spinal cord stimulation devices, sacral neuromodulation therapies, tibial neuromodulation systems, and pelvic health implants engineered for chronic pain management, bladder control, sacral nerve conditions, and urinary urge incontinence.
Medtronic executive team
- Mr. Geoffrey Straub MarthaChairman of the Board & CEO
- Mr. Thierry PietonExecutive VP & CFO
- Mr. Gary CoronaSenior VP of Corporate Finance
- Mr. Brett A. WallExecutive VP & President of Neuroscience Portfolio
- Mr. Mark PloofSenior Vice President of Global Operations and Business Services
- Ms. Denise L. BlomquistVP, Global Controller & Chief Accounting Officer
- Dr. Laura Mauri M.D., M.Sc.Senior VP and Chief Scientific & Medical Officer
- Mr. Ryan WeispfenningVP & Head of Investor Relations
- Ms. Michelle QuinnExecutive VP, General Counsel & Secretary
- Mr. Scott CundySenior VP, Chief Quality, Development, & Innovation Officer